What Is the US Patent System? Understanding Patent Filing in 2026
The United States Patent and Trademark Office (USPTO) sits at the heart of American innovation — a federal agency whose constitutional mandate stretches back to Article I, Section 8, Clause 8 of the U.S. Constitution, which empowers Congress to promote “the Progress of Science and useful Arts.” In practice, the USPTO grants inventors a time-limited exclusive right to their invention in exchange for public disclosure — a bargain that has fueled over two centuries of American technological leadership. There are three principal types of US patents: utility patents (covering new processes, machines, or compositions of matter), design patents (covering ornamental designs for manufactured articles), and plant patents (covering new, asexually reproduced plant varieties). A utility or plant patent is valid for 20 years from the filing date; design patents issued from applications filed on or after May 13, 2015, are valid for 15 years from the date of issue. The USPTO is a fully fee-funded agency headquartered in Alexandria, Virginia.
In 2026, the state of US patent filing is a story of record backlogs, resilient application volumes, shifting technology priorities, and institutional transformation. The patent system absorbed a dramatic rise in applications through the early 2020s, and by January 2025 the unexamined patent application inventory had ballooned to a record 837,928 applications — up by nearly 262,000 from the 576,103 recorded in 2020. New USPTO leadership took over with the Trump administration in early 2025, implementing a series of initiatives to reverse the backlog growth. By the close of Fiscal Year 2025 (ended September 30, 2025), the inventory had been drawn down to 788,229 — a reduction of 49,699 applications, or 5.9%. Meanwhile, AI-related patents have become one of the fastest-growing categories at the USPTO, semiconductor filings continue their record-setting run, and the question of AI inventorship has emerged as a defining legal and policy frontier. The numbers behind all of this are explored in full detail below.
Interesting Key Facts About US Patent Filing in 2026
Before the statistics tables, here are the most fascinating and widely referenced facts about the US patent system and filing landscape — presented in a single, scannable reference table.
| Fact | Detail / Figure |
|---|---|
| First US patent issued | July 31, 1790 — to Samuel Hopkins for a process of making potash |
| USPTO established | 1836 as a formal agency; operating under Department of Commerce |
| Total patents in US history | Utility patent number 11,000,000+ issued as of 2024 |
| FY 2025 total patents issued | 327,641 patents issued (Oct 1, 2024 – Sep 30, 2025) |
| FY 2024 total patents issued | 365,614 patents (all types), including 321,020 utility patents |
| Patent backlog peak | 837,928 unexamined applications in January 2025 — all-time record |
| FY 2025 backlog reduction | Reduced by 49,699 to 788,229 by end of FY 2025 |
| CY 2025 utility patents | ~325,800 utility patents issued — near-identical to 2024’s ~325,600 |
| CY 2025 design patents | ~52,000 — a 10% increase and a new all-time annual record |
| First action pendency (FY 2025) | Averaged 20.5 months from filing to first office action |
| Total pendency FY 2024 | Average 26.1 months from filing to final disposition |
| Pending applications FY 2024 | 1,317,444 total pending (including 114,389 design + 1,203,055 UPR) |
| USPTO revenue FY 2025 | Total revenue increased to $4.42 billion (up from $4.12 billion in FY 2024) |
| USPTO total spending FY 2025 | $4,619,294 thousand (~$4.62 billion) |
| USPTO examiner count FY 2024 | 8,599 UPR patent examiners — highest total since 2021 |
| New examiners hired FY 2024 | 923 new UPR examiners — a 42% increase over prior year |
| Rejection rate | More than 92% of patent applications receive at least one rejection |
| Abandonment after first action | Approximately 12% of applications abandoned after first office action |
| Average claims per application | About 21 claims per patent application |
| Samsung #1 for 5th year | 10,427 patents granted in FY 2025 — most of any single company |
| AI patent growth | AI patents at USPTO grew from 34,544 in 2020 to 54,022 in 2024 |
| Semiconductor patents FY 2024 | 67,118 grants — highest single-year total, up from 49,831 in 2021 |
| Foreign origin share | ~50% of granted utility patents go to foreign-origin applicants |
| Top foreign recipient (FY 2024) | Japan: 40,055 patents; China: 33,524; South Korea: 23,148 |
| USPTO cost savings FY 2025 | Up to $315 million saved by terminating non-critical contracts |
Source: USPTO FY 2025 Agency Financial Report (December 5, 2025); Parola Analytics FY 2025 Patent Roundup; Notaro, Michalos & Zaccaria analysis of USPTO FY 2024 data; USPTO Patents Dashboard (March 2026)
The facts above capture something broader than raw numbers — they tell the story of a patent system at an inflection point. The 837,928-application backlog that peaked in January 2025 did not appear overnight; it was the compounding result of a 2019 reduction in examiner production expectations, pandemic-era staffing disruptions, and filing volumes that proved more resilient than predicted. The fact that 92% of applications receive at least one rejection underscores just how rigorous — and resource-intensive — the USPTO’s examination process is. Meanwhile, the dominance of Samsung at 10,427 patents in FY 2025 and the rise of AI grants from 34,544 in 2020 to 54,022 by 2024 illustrates where the frontier of innovation has been moving: semiconductors, artificial intelligence, and advanced imaging technologies are now the defining battlegrounds of the global patent race.
US Patent Grants Statistics 2024–2025 | Total Numbers by Type
USPTO Patent Grants by Type — FY 2024 vs FY 2025
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Patent Type FY 2024 (All) FY 2025 (All) Change
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Utility 321,020 ~321,500 ~Flat
Design 43,383 ~52,000 +~19.8%
Plant 755 ~800 ~Flat
Reissue 456 ~341 —
Total 365,614 327,641 –10.4%
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Note: FY 2024 = Dec 1 2023–Nov 30 2024 (USPTO fiscal year)
FY 2025 = Oct 1 2024–Sep 30 2025 (USPTO fiscal year)
CY 2025 utility patents: ~325,800 (calendar year basis)
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
| Patent Type | FY 2024 Grants | FY 2025 Grants | Calendar Year 2025 (CY) |
|---|---|---|---|
| Utility (Inventions) | 321,020 | ~321,500 | ~325,800 |
| Design | 43,383 | ~52,000 | ~52,000 (record high) |
| Plant | 755 | ~800 | — |
| Reissue | 456 | ~341 | — |
| Total (All Types) | 365,614 | 327,641 | — |
| YoY Change (Total) | +5.6% vs FY 2023 | +0.2% vs FY 2024 | — |
Source: USPTO FY 2025 Agency Financial Report (December 5, 2025); Parola Analytics FY 2025 US Patent Roundup Report; Patently-O Calendar Year 2025 analysis (December 30, 2025)
The USPTO issued 327,641 total patents in FY 2025 — a figure that looks modest on the surface but masks a dramatic divergence between patent types. On the utility side, the system has entered what analysts are calling a “post-pandemic plateau”: approximately 325,800 utility patents were issued in calendar year 2025, almost indistinguishable from the 325,600 issued in calendar year 2024. This flatness reflects the combination of a stable allowance rate and examination capacity that has been constrained by backlog pressures. The real headline in 2025 is design patents, where approximately 52,000 grants in calendar year 2025 represent a 10% increase over 2024 and mark the highest annual design patent total on record. This surge is driven heavily by non-US applicants — particularly from Asia — who increasingly recognise the value of protecting product aesthetics in the world’s largest consumer market. The fiscal year comparison also reflects a methodology shift between the old December–November fiscal year window used for FY 2024 and the October–September window used for FY 2025, which modestly affects total-count comparisons.
USPTO Patent Application Filings in US 2024–2025 | Volume & Backlog
US Patent Application Filings & Backlog Trend
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Year Total Pending Apps Unexamined Inv. CY Filings (UPR)
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
2020 ~1.0 million 576,103 —
2021 ~1.0 million ~600,000 —
2022 ~1.0 million ~650,000 —
2023 ~1.0 million ~750,000 ~416,000
2024 1,317,444 804,658 (Oct 2024) 430,625
Jan 2025 peak 837,928 (record) —
End FY25 ~788,229 788,229 —
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
FY 2024 total pending (all types): 1,317,444
incl. Design: 114,389 | UPR: 1,203,055
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
| Filing / Backlog Metric | Figure | Period / Notes |
|---|---|---|
| Total Pending Patent Applications (FY 2024) | 1,317,444 | Includes all types; USPTO FY 2024 |
| UPR Pending Applications (FY 2024) | 1,203,055 | Utility, Plant & Reissue only |
| Design Patent Applications Pending (FY 2024) | 114,389 | FY 2024 |
| CY 2024 Utility Patent Application Filings | 430,625 | +3% vs CY 2023; calendar year |
| Unexamined Inventory — Peak (January 2025) | 837,928 | All-time record high |
| Unexamined Inventory — End FY 2025 | 788,229 | After 5.9% reduction by new leadership |
| Backlog Reduction in FY 2025 | –49,699 applications | Sep 30, 2025 vs peak Jan 2025 |
| UPR Applications Pending Growth (2023 to 2024) | From ~1.0M to 1.19M | Sharp increase year-on-year |
Source: USPTO FY 2025 Agency Financial Report (December 5, 2025); NVG-Inc USPTO Patent Trends analysis (May 2025); Patently-O USPTO Patent Grant Rate analysis (November 2024); ipboutiquelaw.com, citing USPTO Patents Dashboard data updated March 2026
The 1,317,444 total pending patent applications sitting at the USPTO in fiscal year 2024 represent the largest pile of unresolved intellectual property claims in the office’s history. The surge from roughly 1.0 million pending applications in 2021–2023 to over 1.19 million UPR applications alone by 2024 was driven by converging pressures: filing volumes hit 430,625 in calendar year 2024 (a 3% increase from 2023), while examination capacity had not kept pace. The consequence for applicants has been real and costly — first action pendency climbed to 20.5 months by January 2025, a 39% increase from the 14.8 months recorded at end of 2020. The new USPTO leadership team, taking over in early 2025, responded with a combination of incentive programs for examiners, reduced non-examination work assignments, and reassignment initiatives that collectively reversed the backlog trend by year-end. Bringing the unexamined inventory down by 49,699 applications by the close of FY 2025 is significant — but with 788,229 applications still waiting for a first office action, the structural challenge remains formidable heading into 2026.
Patent Pendency & Examination Timeline in the US 2025–2026
USPTO Average Patent Pendency Timeline (Utility Patents)
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Stage FY 2024 FY 2025
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
First Office Action Pendency 20.3 mo 20.5 mo (Jan 2025 peak)
Total Pendency (excl. RCEs) 26.1 mo 24–26 mo
Total Pendency (incl. RCEs) — 30–40+ mo
Track One (Prioritized) — 6–12 mo
Design Patent Pendency — 12–18 mo
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
FY 2025 examiner count: 8,599 (UPR)
FY 2024 new hires: 923 examiners (+42% YoY)
FY 2025 target: 850 new hires (~360 over attrition)
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
| Pendency Metric | FY 2024 | FY 2025 / 2026 Status |
|---|---|---|
| Avg First Office Action Pendency | 20.3 months | ~20.5 months (Jan 2025 peak); some sources report ~22.6 months FY 2025 avg |
| Avg Total Pendency (excl. RCEs) | 26.1 months | 24–26 months (applications proceeding cleanly) |
| Avg Total Pendency (incl. RCEs) | — | 30–40+ months |
| Track One Prioritized Examination | — | 6–12 months to final disposition |
| Design Patent Total Pendency | — | 12–18 months |
| UPR Examiner Staff (FY 2024) | 8,599 | Highest since 2021; 923 new hires in FY 2024 |
| USPTO FY 2025 Planned New Hires | — | ~850 patent examiners (~360 over attrition) |
| Examiner Reviews per Month (avg) | ~22 applications | Per examiner; balances efficiency vs thoroughness |
Source: Notaro, Michalos & Zaccaria — USPTO FY 2024 Annual Statistics (February 2025); USPTO FY 2025 Agency Financial Report (December 2025); ipboutiquelaw.com citing USPTO Patents Dashboard, March 2026; USPTO FY 2025 Budget Request
The pendency numbers are arguably the most commercially significant statistics in the entire USPTO dataset — because they directly translate into how long an inventor must wait before their competitive moat is legally secured. The 26.1-month average total pendency in FY 2024, climbing toward that level in FY 2025, means most technology companies are waiting more than two years from filing to grant under standard examination. For AI, software, and biotech applicants, the wait is typically longer — technology-heavy fields have historically run at the upper end or beyond these averages. The pressure-release valve is Track One Prioritized Examination, which targets final disposition within 12 months for an additional government filing fee — a pathway increasingly favoured by startups, companies preparing for fundraising rounds, and product launches where patent pending status needs to convert to an issued patent on a tight commercial timeline. The 923 new examiners hired in FY 2024 — a 42% jump over the prior year — represented the most aggressive hiring push in years, but examiner training takes 18–24 months before it meaningfully moves the backlog needle, meaning the full benefit of that hiring won’t fully appear until 2026 and beyond.
Top Patent Filers & Grantees in the US 2025 | Companies & Countries
Top 10 US Patent Grantees by Company — FY 2025
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Rank Company Country FY 2025 Grants
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
1 Samsung Electronics S. Korea 10,427
2 LG Electronics S. Korea ~5,000+
3 TSMC Taiwan ~4,200+
4 Qualcomm USA —
5 Huawei China (Top filer)
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Top 10 firms contributed 11% of all patents issued in FY 2025
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
| Country of Origin | FY 2024 Patent Grants | Trend |
|---|---|---|
| United States | 158,773 (resident inventors) | –2.8% vs FY 2023 |
| Japan | 40,055 | +9% vs FY 2023 |
| China | 33,524 | +33.8% vs FY 2023 |
| South Korea | 23,148 | +7.6% vs FY 2023 |
| Taiwan | 12,063 | Growing |
| Germany | 15,420 | +10.9% vs FY 2023 — top European nation |
| Canada | 7,069 | Steady |
| Foreign Origin Total (FY 2024) | 184,553 | ~50%+ of all grants |
Source: Notaro, Michalos & Zaccaria — USPTO FY 2024 Annual Statistics (February 2025); Parola Analytics FY 2025 US Patent Roundup Report (December 2025); Anaqua AcclaimIP Analysis of USPTO FY 2024 Data (January 2025)
The country-level patent grant data reveals a pattern that many American policymakers find both impressive and concerning: foreign-origin applicants received 184,553 of the total USPTO grants in FY 2024, meaning non-US entities now account for more than half of all granted US patents. Japan, despite its ageing population and mature economy, surged +9% to 40,055 grants, reflecting deep institutional investment in patent strategy by companies like Toyota, Panasonic, and Sony. The most striking growth story, however, belongs to China — up 33.8% in FY 2024 to 33,524 grants — driven by semiconductor, AI, and telecoms filings from companies like Huawei, BOE, and CNOOC affiliates. On the company side, Samsung’s 10,427 grants in FY 2025 have made it the world’s most prolific US patent recipient for at least the fifth consecutive year. The top 10 companies collectively accounted for 11% of all USPTO grants in FY 2025 — a concentration of IP power that reflects how capital-intensive modern R&D has become. Meanwhile, US-based companies, despite still leading in absolute volume at 158,773, saw a 2.8% decline in their grant share — a trend that has triggered calls for greater domestic R&D investment and patent policy reform.
US Technology Patent Statistics 2024–2025 | AI, Semiconductors & Key Sectors
Top US Patent Technology Fields by Volume — FY 2024 Grants
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Technology Field FY 2024 Grants Growth (2021→2024)
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Semiconductors 67,118 +35% (from 49,831)
Artificial Intelligence 54,022 +56% (from 34,544 in 2020)
Medical/Biotech Top 3 Steady growth
5G / Telecom Top 4 Accelerating
Virtual Reality (VR) Top 5 Rapid growth
Computer Vision (FY 2025) — +16.41% (fastest growing 2025)
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
| Technology Area | FY 2024 Grants | Growth Trend | Key Companies |
|---|---|---|---|
| Semiconductors | 67,118 | +35% since 2021 (3rd straight record year) | Samsung, TSMC, Intel, Qualcomm |
| Artificial Intelligence (AI) | 54,022 | +56% since 2020 (4th year of growth) | Samsung, IBM, Alphabet, BOE, NEC |
| Medical & Biotech | Top 3 field | Consistent annual growth | J&J, Medtronic, Boston Scientific |
| 5G / Telecommunications | Top 4 field | Accelerating — 5G rollout driven | Qualcomm, Ericsson, Nokia, Huawei |
| Virtual Reality (VR) | Top 5 field | Rapid growth | Apple, Meta, Sony, Samsung |
| Computer Vision (FY 2025) | Fastest growing | +16.41% surge in FY 2025 | Samsung, Nvidia, Alphabet |
| 3D Rendering / Image Analysis | Growing | Tied to AI pivot | Multiple tech majors |
| User Interface Devices | Highest volume | Keyboards, touchscreens, displays | Consumer electronics firms |
Source: Anaqua AcclaimIP Analysis of USPTO FY 2024 Patent Data (January 30, 2025); Parola Analytics FY 2025 US Patent Roundup (December 2025)
Semiconductors hold the title of the most-patented technology field at the USPTO for the third consecutive year, with 67,118 grants in FY 2024 — a figure that has grown by more than a third since 2021. The semiconductor patent boom reflects the trillion-dollar global race to dominate chip design, advanced packaging, and next-generation processing architectures — driven by companies like Samsung, TSMC, and Qualcomm who collectively file tens of thousands of applications annually. Artificial intelligence is the growth story of the decade: climbing from 34,544 grants in 2020 to 54,022 in FY 2024 represents a 56% surge in just four years, and 2025 data shows continued acceleration. The +16.41% surge in computer vision patent grants in FY 2025 is a direct signal of where AI applications are heading — autonomous vehicles, robotics, medical imaging, and immersive computing all depend on systems that can “see” and interpret the world, making computer vision IP a strategic asset of enormous commercial value. The biotech and medical device field, ranking consistently in the top three, underscores America’s global leadership in pharmaceutical and medical innovation — a pipeline that feeds directly into the patents-to-products pipeline and influences the cost of healthcare.
USPTO Financial Statistics 2025 | Revenue, Budget & Workforce
USPTO Financial & Workforce Snapshot — FY 2025
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Metric FY 2024 FY 2025
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Total Revenue $4.12B $4.42B (+$300M)
Total Program Cost $4.45B est. $4.62B
Federal Personnel (total) — 13,777
Patent Program FTE Budget (FY25) — 12,373 FTEs/12,774 positions
Contracts Savings (FY25) — Up to $315M
Travel Expenditure Reduction — –72% vs FY 2024
PTA Compliance (Mailed Actions) — 74% actual (target: 80%) NOT MET
35 USC 101 Patent Eligibility — 97.9% actual (target: 94%) MET
35 USC 102 Novelty Compliance — 96.2% actual (target: 94%) MET
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
33rd consecutive year of clean audit opinion (FY 2025)
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
| Financial / Operational Metric | FY 2024 | FY 2025 |
|---|---|---|
| Total Revenue | $4.12 billion | $4.42 billion |
| Total Program Cost | ~$4.45 billion | $4.619 billion |
| Federal Personnel | — | 13,777 employees |
| Patent Program Budget (FTE base) | — | $4,061 million / 12,373 FTEs |
| Contracts Savings (FY 2025) | — | Up to $315 million |
| Travel Expenditure Reduction | — | –72% vs FY 2024 |
| PTA Compliance — Mailed Actions | — | 74% actual (target 80% — Not Met) |
| Statute 101 Eligibility Compliance | — | 97.9% (target 94% — Met) |
| Statute 102 Novelty Compliance | — | 96.2% (target 94% — Met) |
| Consecutive Clean Audit Opinions | 32nd year | 33rd year |
| Customer Trust Score (FY 2025) | — | 82% trust USPTO (target 65% — Met) |
Source: USPTO FY 2025 Agency Financial Report, published December 5, 2025 (official US government document)
The USPTO’s financial performance in FY 2025 tells a story of an agency that grew its revenue base while simultaneously cutting costs through operational restructuring. Total revenue rising to $4.42 billion — a $300 million increase — reflects the steady increase in fee-paying patent and trademark applications, underscoring that even amid economic uncertainty, inventors and corporations continue to view IP protection as a non-negotiable investment. The $315 million in contract savings achieved by the new leadership team in FY 2025 represents an extraordinary efficiency gain — achieved through contract terminations, renegotiations, and the reduction of non-mission-critical spending. The headline miss is Patent Term Adjustment (PTA) compliance at 74% against a target of 80% — PTA provisions require the USPTO to grant extra patent term to compensate inventors for delays the office itself caused, and missing this target means more patents are being granted with extended terms and that examination timelines continue to pressure the system. The strong performance on patentability statute compliance — 97.9% on § 101 eligibility and 96.2% on § 102 novelty — demonstrates that the quality of examination decisions remains high even as volume pressures mount. The 82% customer trust score against a 65% target is perhaps the most underappreciated number in the table: it signals that despite the backlog challenges, inventors and practitioners still broadly trust the USPTO system.
US AI Patent Statistics 2024–2025 | America’s Position in the Global AI Patent Race
Global AI Patent Applications 2024 — Country Comparison
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Country 2024 AI Applications Share (approx.)
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
China ~300,000 ~70% globally
United States ~67,800 ~16%
Japan ~26,400 ~6%
India ~26,000 ~6%
South Korea ~23,700 ~5.5%
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
US AI patents granted: grew from 34,544 (2020) → 54,022 (FY 2024)
Samsung alone filed 6,000+ AI applications globally in 2024
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
| AI Patent Metric | Figure | Year / Notes |
|---|---|---|
| US AI Patents Granted (FY 2024) | 54,022 | 4th consecutive year of growth at USPTO |
| US AI Patents Granted (2020) | 34,544 | Baseline — +56% growth in 4 years |
| China AI Patent Applications (2024) | ~300,000 | ~70% of global total |
| US AI Patent Applications (2024) | ~67,800 | Quality-over-quantity strategy |
| Japan AI Applications (2024) | ~26,400 | Focus: robotics, industrial automation |
| India AI Applications (2024) | ~26,000 | Extraordinary recent growth |
| South Korea AI Applications (2024) | ~23,700 | Samsung leads globally with 6,000+ filings |
| Computer Vision Growth (FY 2025) | +16.41% | Fastest-growing AI subfield at USPTO |
| US August 2025 USPTO AI Memo | Policy Update | Clarified AI/ML patent eligibility rules |
Source: The Rapacke Law Group citing USPTO and global IP office data (May 2025); Anaqua FY 2024 Patent Analysis (January 2025); Parola Analytics FY 2025 Report; USPTO August 2025 AI Patent Eligibility Memo
The global AI patent race is one of the defining IP storylines of this decade, and the numbers reveal a striking contrast in strategy between the US and China. China filed approximately 300,000 AI patent applications in 2024 — roughly 70% of all global AI filings — reflecting a state-directed drive to accumulate IP breadth across every conceivable AI application domain. The United States filed approximately 67,800 AI applications in the same period, a far smaller absolute number, but American AI patents are consistently described as higher-citation, broader in scope, and more commercially fundamental. The US “quality over quantity” strategy means American AI patents tend to cover core algorithms, training methodologies, and fundamental architectures that underpin many downstream applications. At the USPTO, AI grants grew from 34,544 in 2020 to 54,022 in FY 2024 — a 56% increase in four years — reflecting both genuine innovation acceleration and the broadening of AI technology into sectors like healthcare, finance, autonomous vehicles, and industrial robotics. The August 2025 USPTO memo on AI patent eligibility clarified how AI and machine learning inventions can satisfy § 101 subject matter eligibility requirements — a critical policy development that directly shapes what kinds of AI innovations can be patented in America going forward.
US State-by-State Patent Grant Statistics 2024 | Top Innovation Hubs
Top US States by Patent Grants — FY 2024 (Resident Inventors)
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
State Grants Share of US-Resident Total
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
California 46,454 29.3% ████████████████████████████
Texas 11,552 7.3% ██████
Massachusetts 7,976 4.8% ████
New York 7,605 4.8% ████
Washington 6,560 4.1% ███
Others 78,626 49.7%
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Total US-Resident Grants FY 2024: 158,773
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
| US State | FY 2024 Patent Grants | Share of US-Resident Grants |
|---|---|---|
| California | 46,454 | 29.3% |
| Texas | 11,552 | 7.3% |
| Massachusetts | 7,976 | 4.8% |
| New York | 7,605 | 4.8% |
| Washington State | 6,560 | 4.1% |
| All Other States | ~78,626 | ~49.7% |
| Total US-Resident Grants | 158,773 | 100% of domestic share |
Source: Notaro, Michalos & Zaccaria analysis of USPTO FY 2024 Annual Data (February 2025)
California’s dominance is absolute and enduring — accounting for 29.3% of all US-resident patent grants in FY 2024 with 46,454 patents, the state’s innovation density reflects the concentration of technology giants, semiconductor companies, biotech firms, and venture-backed startups in Silicon Valley and the broader Bay Area. Put another way, California alone out-patents nations like South Korea in terms of absolute grant volumes from a single geography. Texas at 11,552 grants has been one of the fastest-rising innovation hubs over the past decade, buoyed by the relocation of major tech companies — Tesla, Oracle, and a flood of semiconductor manufacturers — to the Austin–Dallas–Houston corridor. Massachusetts at 7,976 punches far above its geographic size, driven by MIT, Harvard, and the deep biotech and medtech cluster around the Route 128 corridor. Washington State at 6,560, anchored by Microsoft and Amazon’s respective research operations, rounds out a top five that tells a coherent geographic story: the US patent ecosystem is clustered around a handful of innovation corridors, raising persistent questions about whether federal R&D incentives are doing enough to spread innovation capacity to the rest of the country.
Quick Reference: Key US Patent Filing Statistics 2026
| Statistic | Figure | Source / Period |
|---|---|---|
| Total Patents Issued — FY 2025 | 327,641 | USPTO FY 2025 |
| Total Patents Issued — FY 2024 | 365,614 | USPTO FY 2024 |
| Utility Patents — CY 2025 | ~325,800 | Calendar year basis |
| Design Patents — CY 2025 | ~52,000 (record high) | Calendar year basis |
| Total Pending Applications — FY 2024 | 1,317,444 | All types |
| Unexamined Backlog Peak (Jan 2025) | 837,928 | All-time record |
| Unexamined Backlog (End FY 2025) | 788,229 | After 5.9% reduction |
| CY 2024 Utility Filings | 430,625 | +3% vs CY 2023 |
| First Action Pendency (FY 2024) | 20.3 months | Average |
| Total Pendency (FY 2024) | 26.1 months | Average excl. RCEs |
| USPTO Total Revenue (FY 2025) | $4.42 billion | Up from $4.12B in FY 2024 |
| USPTO Total Program Cost (FY 2025) | $4.619 billion | |
| USPTO Contract Savings (FY 2025) | Up to $315 million | New leadership initiative |
| UPR Examiners (FY 2024) | 8,599 | Highest since 2021 |
| New Examiners Hired FY 2024 | 923 | +42% over prior year |
| Samsung FY 2025 Grants | 10,427 | #1 company globally |
| US-Resident Grants FY 2024 | 158,773 | –2.8% vs FY 2023 |
| China Grants at USPTO FY 2024 | 33,524 | +33.8% vs FY 2023 |
| AI Patents — FY 2024 Grants | 54,022 | +56% since 2020 |
| Semiconductor Patents — FY 2024 | 67,118 | 3rd record year running |
| California Share of US Grants | 29.3% | 46,454 patents in FY 2024 |
| Applications Receiving ≥1 Rejection | >92% | Standard examination |
| Average Claims per Application | ~21 claims | USPTO data |
| Track One Pendency | 6–12 months | Prioritized examination fee |
Source: USPTO FY 2025 Agency Financial Report (December 5, 2025); USPTO Patents Dashboard (March 2026); Parola Analytics FY 2025 Patent Roundup (December 2025); Notaro, Michalos & Zaccaria USPTO FY 2024 Analysis (February 2025); Anaqua AcclaimIP FY 2024 Patent Analysis (January 2025)
The summary table above brings together every major data point from the most current and verified official sources available as of April 30, 2026. Several numbers deserve special emphasis as indicators of where the US patent system stands today. The 788,229-application backlog, while reduced from its January 2025 peak, remains historically massive and continues to burden applicants with pendency times that stretch utility patent protection timelines well past the two-year mark. The $4.42 billion in revenue demonstrates that the USPTO is financially healthy — its fee-funded model insulates it from Congressional appropriations battles in a way that most federal agencies cannot claim. The China grant surge of +33.8% in FY 2024 to 33,524 USPTO patents is perhaps the most geopolitically charged data point in the table: Chinese entities are filing and winning more American patents than ever before, raising questions about IP security, technology transfer, and the adequacy of current examination scrutiny. And the 56% growth in AI patent grants since 2020 confirms that artificial intelligence is no longer a niche technology field at the USPTO — it is now one of the core pillars of the American innovation economy, its contours being actively reshaped by both examiner guidance memos and the landmark policy questions around whether AI-assisted inventions can satisfy the human-inventor requirement under US patent law.
Disclaimer: This research report is compiled from publicly available sources. While reasonable efforts have been made to ensure accuracy, no representation or warranty, express or implied, is given as to the completeness or reliability of the information. We accept no liability for any errors, omissions, losses, or damages of any kind arising from the use of this report.

